Data from a recent randomized controlled clinical trial suggest that radiofrequency ablation of low grade dysplasia (LGD) is superior to continued endoscopic surveillance among patients with LGD confirmed by a panel of expert gastrointestinal pathologists. In this video, Gary Falk, MD, discusses this and other studies that are redefining the indications for RFA in patients with pathologist-confirmed LGD.
Related Links
Published
August 4, 2016
Created by
BROADCASTMED